FDA proposes competency-based evaluations for generative AI medical devices

The FDA is proposing a shift to competency-based testing for generative AI medical devices, with public feedback due by Oct. 19, 2026. The agency has already authorized over 1,000 AI-enabled devices, but the new framework would require benchmark suites, postmarket monitoring, and contract updates...